Showing 2,241 - 2,260 results of 2,897 for search '"Stem cell"', query time: 0.07s Refine Results
  1. 2241

    Regulatory Immunotherapy in Bone Marrow Transplantation by Vanessa Morales-Tirado, Wioleta Luszczek, Marié van der Merwe, Asha Pillai

    Published 2011-01-01
    “…Every year individuals receive hematopoietic stem cell transplantation (HSCT) to eradicate malignant and nonmalignant disease. …”
    Get full text
    Article
  2. 2242
  3. 2243
  4. 2244
  5. 2245
  6. 2246
  7. 2247

    Understanding the multifaceted nature of peptide hydrogels in biomedical research by Srestha Ghosh, Shinjini Chaudhuri, Subhabrata Guha, Gaurav Das

    Published 2024-03-01
    “…In this review, we will present the recent advancements that have occurred in the field of peptide-based hydrogels concerning its biomedical applications especially delivery of targeted delivery, wound healing, tissue engineering, stem cell therapy, etc.…”
    Get full text
    Article
  8. 2248

    Current developments in personalized treatment strategies for elderly acute myelogenous leukemia patients by Xueting Hou, Jizhang Bao

    Published 2025-01-01
    “…Acute myelogenous leukemia(AML) is a life-threatening hematologic malignancy that predominantly affects the elderly.Currently, chemotherapy and hematopoietic stem cell transplantation are the primary treatment modalities for AML, though their clinical application is limited in older patients.Recent years have seen the development of novel molecular targeted therapies, such as isocitrate dehydrogenase 1/2 (IDH1/2) and Feline macrophage stimulator-like tyrosine kinase 3 (FLT3) inhibitors, as well as individualized approaches like chimeric antigen receptor T-cell (CAR-T) therapy.However, due to patient heterogeneity and drug resistance, treatment outcomes for elderly AML remain unsatisfactory, underscoring the need for more precise and safer individualized treatment strategies.The combination of chemotherapy with novel targeted or immunotherapies shows promise as a future treatment direction.This research reviews the latest advances in the treatment of elderly AML, with a focus on achieving more individualized and safer therapeutic approaches.…”
    Get full text
    Article
  9. 2249

    The Urodele Limb Regeneration Blastema: The Cell Potential by Kenyon S. Tweedell

    Published 2010-01-01
    “…Other cells from the dermis act as multipotent stem cells that replenish dermal fibroblasts and differentiate into cartilage. …”
    Get full text
    Article
  10. 2250

    Florid Proliferation of Hyalinized Vessels in a Spermatic Cord STAT6 Positive Solitary Fibrous Tumor and Its Potential Clinical Implications by Christopher P. Marquez, Haiyan Zhang, Jason Goodrum, J. Nicholas Sreshta, Marjan Afrouzian

    Published 2018-01-01
    “…We also summarize our current understanding of the structural and molecular features that make up SFTs and discuss how these features may help us better understand the pathophysiology of pluripotent mesenchymal stem cell differentiation.…”
    Get full text
    Article
  11. 2251

    The Role of Bacteria and Pattern Recognition Receptors in GvHD by E. Holler, K. Landfried, J. Meier, M. Hausmann, G. Rogler

    Published 2010-01-01
    “…Graft-versus-Host Disease (GvHD) is the most serious complication of allogeneic stem cell transplantation (SCT) and results from an activation of donor lymphocytes by recipient antigen-presenting cells (APCs). …”
    Get full text
    Article
  12. 2252

    Tracheobronchial Manifestations of Aspergillus Infections by Rafal Krenke, Elzbieta M. Grabczak

    Published 2011-01-01
    “…Thus, invasive or potentially invasive Aspergillus airway diseases are discussed separately in three groups of patients: (1) lung transplant recipients, (2) highly immunocompromised patients with hematologic malignancies and/or patients undergoing hematopoietic stem cell transplantation, and (3) the remaining, less severely immunocompromised patients or even immunocompetent subjects.…”
    Get full text
    Article
  13. 2253

    Small-Sized Clone of T Cells in Multiple Myeloma Patient after Auto-SCT: T-LGL Leukemia Type or Clonal T-Cell Aberration? by Giuseppe Mele, Marilena Greco, Maria Rosaria Coppi, Giacomo Loseto, Angela Melpignano, Salvatore Mauro, Gianni Quarta

    Published 2013-01-01
    “…Second cancers and particularly postransplant lymphoproliferative disorders (PTLDs) are extremely rare in patients undergoing autologous peripheral blood stem cell transplantation (auto-SCT). We report the case of clonally rearranged T-cell expansion which occurred after auto-SCT for Multiple Myeloma (MM). …”
    Get full text
    Article
  14. 2254

    Revolutionizing acute myeloid leukemia treatment: a systematic review of immune-based therapies by Ugochi Ebinama, Binsah George

    Published 2025-01-01
    “…Abstract The established protocol for the management of acute myeloid leukemia (AML) has traditionally involved the administration of induction chemotherapy, followed by consolidation chemotherapy, and subsequent allogeneic stem cell transplantation for eligible patients. However, the prognosis for individuals with relapsed and refractory AML remains unfavorable. …”
    Get full text
    Article
  15. 2255

    Plasma Cell Leukemia: A Review of 3 Cases Managed in Kenya by Matilda Ong’ondi, Elizabeth Kagotho

    Published 2021-01-01
    “…Treatment with novel agents followed by autologous stem cell transplant in those who are transplant eligible leads to better outcomes.…”
    Get full text
    Article
  16. 2256

    Long-Term Use of Ruxolitinib in an AML Patient with Posttransplant Steroid Refractory GVHD by Philip T. Sobash, Achuta K. Guddati, Vamsi Kota

    Published 2020-01-01
    “…We present a case of a 32-year-old male on ruxolitinib with GVHD status postmatched unrelated donor stem cell transplant (MUD SCT) for acute myeloid leukemia (AML) with FLT3 mutation currently on ruxolitinib for 5 years who is not able to tolerate reduction in dosage due to flare-ups. …”
    Get full text
    Article
  17. 2257

    Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease by Gursel Gunes, Haluk Demiroglu, Hakan Goker, Umit Yavuz Malkan, Eylem Eliacik, Okan Yayar, Yahya Buyukasik

    Published 2015-01-01
    “…Chronic graft-versus-host disease (cGVHD) is one of the most important causes of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (aHSCT). Occurring in 30% to 70% of patients, cGVHD has a median time to onset of 4 to 6 months and most cases present within 2 years after aHSCT. …”
    Get full text
    Article
  18. 2258
  19. 2259

    Cavernous Nerve Injury Resulted Erectile Dysfunction and Regeneration by Nan Jiang, Cheng Wu, Xunrong Zhou, Guanghua Zhai, Jian Wu

    Published 2021-01-01
    “…In addition, such as neuromodulatory proteins, proimmune ligands, gene therapy, stem cell therapy, and the current cutting-edge low-energy shock wave therapy have shown advantages in basic research and limited clinical studies. …”
    Get full text
    Article
  20. 2260

    Therapeutic Activity of Lenalidomide in Mantle Cell Lymphoma and Indolent Non-Hodgkin’s Lymphomas by Marco Gunnellini, Lorenzo Falchi

    Published 2012-01-01
    “…Alternative chemoimmunotherapy regimens are often used as salvage strategy and stem cell transplant remains an option for selected patients. …”
    Get full text
    Article